首页> 美国卫生研究院文献>Schizophrenia Bulletin >Meta-analysis of Positive and Negative Symptoms Reveals Schizophrenia Modifier Genes
【2h】

Meta-analysis of Positive and Negative Symptoms Reveals Schizophrenia Modifier Genes

机译:阳性和阴性症状的荟萃分析揭示了精神分裂症修饰基因

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Evidence suggests that genetic factors may influence both schizophrenia (Scz) and its clinical presentation. In recent years, genome-wide association studies (GWAS) have demonstrated considerable success in identifying risk loci. Detection of “modifier loci” has the potential to further elucidate underlying disease processes. Methods: We performed GWAS of empirically derived positive and negative symptom scales in Irish cases from multiply affected pedigrees and a larger, independent case–control sample, subsequently combining these into a large Irish meta-analysis. In addition to single-SNP associations, we considered gene-based and pathway analyses to better capture convergent genetic effects, and to facilitate biological interpretation of these findings. Replication and testing of aggregate genetic effects was conducted using an independent European-American sample. Results: Though no single marker met the genome-wide significance threshold, genes and ontologies/pathways were significantly associated with negative and positive symptoms; notably, NKAIN2 and NRG1, respectively. We observed limited overlap in ontologies/pathways associated with different symptom profiles, with immune-related categories over-represented for negative symptoms, and addiction-related categories for positive symptoms. Replication analyses suggested that genes associated with clinical presentation are generalizable to non-Irish samples. Conclusions: These findings strongly support the hypothesis that modifier loci contribute to the etiology of distinct Scz symptom profiles. The finding that previously implicated “risk loci” actually influence particular symptom dimensions has the potential to better delineate the roles of these genes in Scz etiology. Furthermore, the over-representation of distinct gene ontologies/pathways across symptom profiles suggests that the clinical heterogeneity of Scz is due in part to complex and diverse genetic factors.
机译:背景:证据表明遗传因素可能影响精神分裂症(Scz)及其临床表现。近年来,全基因组关联研究(GWAS)已显示出在识别风险基因座方面的巨大成功。检测“修饰基因座”有可能进一步阐明潜在的疾病过程。方法:我们在爱尔兰病例中通过经验得出的阳性和阴性症状量表的GWAS,来自多个受影响的家系和较大的独立病例对照样本,然后将其合并为大型的爱尔兰荟萃分析。除了单SNP关联外,我们还考虑了基于基因的分析和途径分析,以更好地捕获会聚的遗传效应,并促进对这些发现的生物学解释。使用独立的欧美样本进行总遗传效应的复制和测试。结果:尽管没有单一标记物达到全基因组显着性阈值,但是基因和本体论/途径与阴性和阳性症状显着相关。尤其是NKAIN2和NRG1。我们观察到与不同症状特征相关的本体/途径重叠有限,阴性症状的免疫相关类别过多,阳性症状的成瘾相关类别过多。复制分析表明,与临床表现相关的基因可推广至非爱尔兰样品。结论:这些发现强有力地支持了修饰基因座有助于独特的Scz症状特征的病因学的假说。先前牵涉到的“风险基因座”实际上影响特定症状范围的发现有可能更好地描述这些基因在Scz病因中的作用。此外,症状表现形式中不同基因本体论/途径的过度表达表明,Scz的临床异质性部分归因于复杂多样的遗传因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号